Tubulin-binding compounds, compositions and uses related thereto
US10913750B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2019 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Sep 17, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This disclosure relates to methods of treating cancer (e.g., melanoma) with (MI-181).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.